UroGen Pharma CMO Mark Schoenberg sells 60,677 common shares for $2.86 millionPUBT·14 hours agoURGN-1.49%
IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies | URGN Stock NewsStockTitan·Aug 19 at 10:05 PMURGN-1.49%
Urogen Pharma (NASDAQ:URGN) Reaches New 1-Year High - Here's What HappenedMarket Beat·Aug 19 at 10:00 AMURGN-1.49%BLK+1.39%
Urogen Pharma (NASDAQ:URGN) Hits New 1-Year High - Time to Buy?Market Beat·Aug 12 at 12:00 PMURGN-1.49%
UroGen Pharma (URGN) Is Up 21.7% After Q2 Revenue Triples And Loss Narrows Has The Bull Case Changed?Simplywall·Aug 10 at 06:33 PMURGN-1.49%
Urogen Pharma (NASDAQ:URGN) Hits New 1-Year High - What's Next?Market Beat·Aug 6 at 05:00 AMURGN-1.49%
